IL124356A - A rapid-release tablet containing tolphenic acid or its permitted salt for medical use - Google Patents

A rapid-release tablet containing tolphenic acid or its permitted salt for medical use

Info

Publication number
IL124356A
IL124356A IL12435696A IL12435696A IL124356A IL 124356 A IL124356 A IL 124356A IL 12435696 A IL12435696 A IL 12435696A IL 12435696 A IL12435696 A IL 12435696A IL 124356 A IL124356 A IL 124356A
Authority
IL
Israel
Prior art keywords
tablet
weight
pharmaceutically acceptable
acceptable salt
tolfenamic acid
Prior art date
Application number
IL12435696A
Other languages
English (en)
Hebrew (he)
Other versions
IL124356A0 (en
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of IL124356A0 publication Critical patent/IL124356A0/xx
Publication of IL124356A publication Critical patent/IL124356A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12435696A 1995-12-20 1996-12-19 A rapid-release tablet containing tolphenic acid or its permitted salt for medical use IL124356A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK144895 1995-12-20
PCT/DK1996/000548 WO1997022340A1 (en) 1995-12-20 1996-12-19 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof

Publications (2)

Publication Number Publication Date
IL124356A0 IL124356A0 (en) 1998-12-06
IL124356A true IL124356A (en) 2001-05-20

Family

ID=8104933

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12435696A IL124356A (en) 1995-12-20 1996-12-19 A rapid-release tablet containing tolphenic acid or its permitted salt for medical use

Country Status (27)

Country Link
US (1) US6036975A (et)
EP (1) EP0869783B1 (et)
JP (1) JP2000515489A (et)
CN (1) CN1147295C (et)
AR (1) AR004395A1 (et)
AT (1) ATE234085T1 (et)
AU (1) AU1190097A (et)
BR (1) BR9612057A (et)
CA (1) CA2244396A1 (et)
CZ (1) CZ293422B6 (et)
DE (1) DE69626676T2 (et)
DK (1) DK0869783T3 (et)
EE (1) EE9800186A (et)
ES (1) ES2191781T3 (et)
HR (1) HRP960598A2 (et)
HU (1) HU224030B1 (et)
IL (1) IL124356A (et)
MX (1) MX9803918A (et)
NO (1) NO316869B1 (et)
NZ (1) NZ324674A (et)
PL (1) PL186915B1 (et)
RO (1) RO117589B1 (et)
RU (1) RU2166939C2 (et)
TR (1) TR199801126T2 (et)
TW (1) TW430561B (et)
WO (1) WO1997022340A1 (et)
ZA (1) ZA9610714B (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
IL150053A0 (en) * 1999-12-06 2002-12-01 Mendell Co Inc Edward Pharmaceutical superdisintegrant
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US20050084914A1 (en) * 2003-09-15 2005-04-21 Foulkes J. G. Assays with primary cells
EP1998763A4 (en) * 2006-03-24 2010-03-03 Texas A & M Univ System And Sa USES OF DIPHENYLCARBOXYLIC ACIDS AND CARBOXYLIC ACIDS WITH DIPHENYLAMINE FUNCTION
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US11389454B2 (en) * 2016-09-07 2022-07-19 Celgene Corporation Tablet compositions
CN111184707B (zh) * 2020-02-20 2021-04-27 中山大学 托芬那酸或其药学上可接受的盐在制备预防和/或治疗新型冠状病毒炎症药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE116061C (et) *
FI89004C (fi) * 1988-02-16 1993-08-10 Pertti J Neuvonen Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat
IT1276689B1 (it) * 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale

Also Published As

Publication number Publication date
HUP9903410A2 (hu) 2000-04-28
NZ324674A (en) 2000-01-28
CZ194398A3 (cs) 1998-11-11
PL186915B1 (pl) 2004-03-31
EP0869783B1 (en) 2003-03-12
RU2166939C2 (ru) 2001-05-20
HUP9903410A3 (en) 2000-05-29
ATE234085T1 (de) 2003-03-15
CN1208345A (zh) 1999-02-17
HRP960598A2 (en) 1998-02-28
NO982875L (no) 1998-08-19
DK0869783T3 (da) 2003-06-02
DE69626676T2 (de) 2003-12-18
TR199801126T2 (xx) 1998-08-21
DE69626676D1 (de) 2003-04-17
IL124356A0 (en) 1998-12-06
CN1147295C (zh) 2004-04-28
TW430561B (en) 2001-04-21
WO1997022340A1 (en) 1997-06-26
AR004395A1 (es) 1998-11-04
CZ293422B6 (cs) 2004-04-14
ES2191781T3 (es) 2003-09-16
AU1190097A (en) 1997-07-14
US6036975A (en) 2000-03-14
RO117589B1 (ro) 2002-05-30
EP0869783A1 (en) 1998-10-14
NO316869B1 (no) 2004-06-07
BR9612057A (pt) 1999-02-23
JP2000515489A (ja) 2000-11-21
NO982875D0 (no) 1998-06-19
HU224030B1 (hu) 2005-05-30
ZA9610714B (en) 1997-06-30
EE9800186A (et) 1998-12-15
PL327584A1 (en) 1998-12-21
CA2244396A1 (en) 1997-06-26
MX9803918A (es) 1998-09-30

Similar Documents

Publication Publication Date Title
CA2301132C (en) Rapidly disintegrating methylcellulose tablets
DE60221691T3 (de) Tamsulosin tabletten ohne nahrungsmitteleffekt
US7732492B2 (en) Nateglinide-containing preparation
RU2201754C2 (ru) Фармацевтический состав, способ его получения, способ лечения психотических состояний и гиперактивности
AU9202298A (en) Rapidly disintegrating methylcellulose tablets
CN107811980A (zh) 快速溶解固体剂型
JPH10194969A (ja) 錠剤組成物
MXPA02010347A (es) Composicion.
AU748359B2 (en) Controlled-release formulations
US6036975A (en) Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
WO2006105482A2 (en) Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same
KR20000015865A (ko) 칼륨, 나트륨 및 트리스옥사프로진염의 약학적 제제
GB2067900A (en) Tablets containing trimethoprim, sulphamethoxazole and polyvinylpyrrolidone
JP6328138B2 (ja) Ｎ−［５−［２−（３，５−ジメトキシフェニル）エチル］−２ｈ−ピラゾール−３−イル］−４−［（３ｒ，５ｓ）−３，５−ジメチルピペラジン−１−イル］ベンズアミドの医薬製剤
JPH08507305A (ja) パラセタモールとｌ−システイン又はその先駆体とを含む薬剤組成物
IE57220B1 (en) Ph independent controlled releasable tablets
HU204997B (en) Process for producing carrier system suitable for ensuring controlled biological access to dihydropyridines, as well as new oral dosage form ensuring improved biological access
CA2174538A1 (en) Base for sustained-release preparation, sustained-release preparation, and process for producing the preparation
CA2550041A1 (en) Rapidly disintegrating methylcellulose tablets
AU2004237813A1 (en) Rapidly disintegrating methylcellulose tablets
CA2543223A1 (en) Rapidly disintegrating methylcellulose tablets
MXPA00001857A (en) Rapidly disintegrating methylcellulose tablets
MXPA01006202A (es) Formulacion de liberacion controlada de sodio de divalproex

Legal Events

Date Code Title Description
FF Patent granted